To ensure you receive your Boston.com e-mails, please add newsletters@boston.com to your address book. If you have trouble reading this e-mail, go to http://www.boston.com/business/ticker_headlines
Daily Business Update Get up-to-the-minute Business Updates More Business News »
Thu. Dec. 27, 2012 Lawyer files objection to Upper Crust bidder that allegedly has ties to founder of bankrupt pizza chain A lawyer representing former Upper Crust pizza workers on Wednesday filed an objection in US Bankruptcy Court to the sale of any of the pizza chain’s stores to entities affiliated with founder Jordan Tobins. Upper Crust filed for bankruptcy protection in October and at an auction held last week, the high bidder for the assets of four former Upper Crust locations was UC Acquisition, an entity attorney Shannon Liss-Riordan alleges it has ties to Tobins.	Advertisement
Parexel, Waltham biotech company, buys software maker Liquent for $72 million Parexel International Corp., a Waltham biotechnology services company , said Thursday it has purchased software maker Liquent Inc. for $72 million. Liquent, based in Horsham, Pa., makes software used by drug companies to manage regulatory submissions and product registration. The purchase of Liquent will allow Parexel to expand the consulting services it provides to biotech and medical device companies. Liquent brings to Parexel more than 200 clients worldwide that use its software. Prior to the sale, Liquent was owned by private equity firm Marlin Equity Partners of Hermosa Beach, Calif.
November home sales in Mass. highest since 2005 Motivated homebuyers purchased 4,539 single-family properties last month, the best November for sales since the market peak in 2005, according to data released Thursday. Sales of single-family homes increased by 38 percent in November compared to the same month in 2011, the 11th month in a row of sales increases, according to the Warren Group, a Boston company that tracks local real estate.
Cellceutix stock surging on optimism about new cancer drug Beverly biotech company Cellceutix Corp. surged again on Wednesday, pushing its stock price up by 30 percent in two days of trading since it claimed to be ahead of giants Merck, Roche and Sanofi in the race to develop a new cancer drug. Cellceutix closed trading on the Nasdaq exchange at $2.42 per share on Wednesday, an all-time high since the company went public in February 2008. As recently as Nov. 26, a share of Cellceutix cost $0.98.
Chevron to pay $1.7m to settle case alleging improper payments from state fund Chevron USA, Inc. and Texaco Downstream Properties, Inc. will repay the state $1.7 million to settle a lawsuit alleging they accepted money from a public fund for gas station cleanups without disclosing reimbursement payments from their insurers, Attorney General Martha Coakley announced on Wednesday. The repayment announced Wednesday is the second in Coakley’s crusade against misuse of the cleanup fund. In April, Sunoco agreed to a $2.2 million settlement in a similar case.
Boston-area home prices rising, but more slowly than in other large cities Home prices in Boston have risen in the past year but at a much slower pace than in other major housing markets, according to the Standard & Poor’s/Case-Shiller home price index released on Wednesday. Boston housing prices were 1.6 percent higher in October this year than they were in the same month last year. The average increase in 20 metropolitan areas was 4.3 percent -- the largest year-over-year increase in two and a half years.
Logan Airport breaks passenger record For the second year in a row, Logan International Airport recorded a record number of passengers with 29 million travelers passing through the Boston airport. The airport will mark the occasion this afternoon by welcoming the 29th million traveler, who is expected to depart on a United Airlines flight later Wednesday afternoon. The airport’s previous passenger record was set in 2011 when 28.9 million travelers flew in and out of Logan.
Cambridge biotech Aegerion wins FDA approval for drug to treat rare form of high cholesterol Aegerion Pharmaceuticals said Monday it has won approval from the Food and Drug Administration to market the Cambridge biotechnology company’s first drug, a treatment for a rare inherited genetic disorder that can raise cholesterol to life-threatening levels. The condition, disordehomozygous familial hypercholesterolemia -- or HoFH -- is resistant to statins and other medications typically used to bring high cholesterol under control.
Beverly pharmaceutical company claims it’s at leading edge of research on new cancer drug Beverly-based biopharmaceutical company Cellceutix Corp. on Monday said a cancer drug it is testing in clinical trials is more advanced than similar drugs under development by larger companies that were featured in The New York Times on Sunday. Merck, Roche and Sanofi are not yet testing their drugs in clinical trials against many kinds of cancer but Cellceutix, which was not mentioned in the Times article, said Monday that it is already conducting such trials.
Union files complaint against UMass Memorial after some nurses told to work on Christmas Unionized nurses have filed an unfair labor practice complaint with the National Labor Relations Board charging that UMass Memorial Medical Center in Worcester was breaching its contract and violating federal labor law by requiring some nurses to work on Christmas. Between 10 and 20 nurses were told in recent days that they will be needed on Christmas even though they worked on Thanksgiving and are scheduled to work on New Year’s day, said David Schildmeier, spokesman for the Massachusetts Nurses Association.
Massachusetts pension fund has about $28 million invested in the US gun industry State treasurer Steve Grossman said the Massachusetts pension fund has $27.8 million invested in the gun industry. The Globe reported earlier this week that Grossman had asked for an accounting of gun-related investments following last Friday’s mass shooting at Sandy Hook Elementary School in Newtown, Conn. “Given recent events, we’re engaged in a serious conversation on gun violence in America, and I hope that the timely release of this information will make that as comprehensive a discussion as possible,” Grossman said in a statement Friday.
ADVERTISEMENT Looking to catch the next big game in town? Search from a wide range of Red Sox, Bruins, Celtics and Patriots seats in our exclusive ticket section powered by Ace Ticket. For the best seats to any sporting event in Boston, go to Boston.com Tickets.